4.5 Interaction with other medicinal products and other forms of interaction 
 Dif f erent injectable vaccines should always be administered at dif f erent injection sites.Immunosuppressive therapies may reduce the immune responses to vaccines.Inf ants and children aged 6
 weeks to less than 2  years 
 Vaxneuvance
 can be given concomitantly with any of  the following vaccine antigens, either asmonovalent or combination vaccines: diphtheria, tetanus, pertussis,
 poliomyelitis
 (serotypes 1, 2and 3), hepatitis A, hepatitis B, Haemophilus influenzae type b, measles, mumps, rubella, varicella androtavirus vaccine
.Children and adolescents 2 to less than 18  years of  age 
 There are no data on the concomitant administration of  Vaxneuvance
 with other vaccines.Data f rom a post
-marketing clinical study evaluating the impact of  prophylactic use of antipyretics(ibuprof en and paracetamol) on the immune response to other pneumococcal vaccines suggest thatadministration of  antipyretics concomitantly or within the same day of  vaccination may reduce theimmune response af ter the inf ant series. Responses to the booster dose administered at 12 months wereunaf f ected. The clinical signif icance of  this observation is unknown.Adults Vaxneuvance
 can be administered concomitantly with seasonal quadrivalent inf luenza vaccine
 (splitvirion, inactivated)
. There are no data on the concomitant administration of  Vaxneuvance
 with othervaccines.
